Hereditary hemorrhagic telangiectasia (HHT), also known as Osler-Weber-Rendu
syndrome, is an autosomal dominant disorder that causes abnormal blood vessel formation …

Hereditary haemorrhagic telangiectasia, inherited as an autosomal dominant trait, affects
approximately 1 in 5000 people. The abnormal vascular structures in HHT result from …

Hereditary haemorrhagic telangiectasia (HHT) is a multisystemic vascular dysplasia that
leads to nosebleeds, anaemia due to blood loss, and arteriovenous malformations (AVMs) …

Hereditary hemorrhagic telangiectasia (HHT) or Rendu-Osler-Weber disease is a genetic
disorder with autosomal dominance and variable penetrance, characterized by epistaxis …

Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant vascular disorder
that leads to abnormal connections between arteries and veins termed arteriovenous …

Background Pulmonary arteriovenous malformations are abnormal direct connections
between the pulmonary artery and pulmonary vein which result in a right‐to‐left shunt. They …

Objectives: Studies report that the risks of significant neurologic complications (including
stroke, cerebral abscess, and migraine) and hemorrhagic sequelae are high in patients with …

Hereditary hemorrhagic telangiectasia (HHT), also called Osler–Weber–Rendu syndrome, is
an autosomal dominant genetic disease that affects the vasculature of numerous organs …

Endoglin is a homodimeric cell membrane glycoprotein receptor for transforming growth
factor β and bone morphogenetic proteins. Endoglin is essential for angiogenesis, being …

Background Hereditary haemorrhagic telangiectasia (HHT) is an autosomal dominant
genetic disorder of aberrant blood vessel development characterised by arteriovenous …